"Effects of Novel Synthetic Nucleosides as Anti-Tumor Agents on Human A" by Salma Awad Merghani Mahmoud

Date of Award

2006

Document Type

Thesis

Degree Name

Master of Science (MS)

Department

Environmental Science

First Advisor

Dr. Ahmed AI-Marzouqi

Second Advisor

Dr. Sehammudine Galadari

Third Advisor

Prof. Evelyn Tiffany-CastigJioni

Abstract

Nucleosides and their analogs are considered a clinically proven class of therapeutic agents possessing anticancer and antiviral activity. Several trifluoromethyl-substituted pyrazole N-nucleosides (coded NIA, NIIA and NIIA) and their nucleobases were synthesized and tested for the ability to induce apoptosis in acute human promyelocytic cell line (HL-60). The growth and proliferation of HL-60 was more effectively inhibited by NIA, NIIA and their nucleobases compared to NIIIA and its nucleobase. In addition, DNA fragmentation was detected in a concentration-dependent manner as a result of nucleosides treatment. A caspase-3-dependent apoptosis was observed based on the Western blot analysis of poly-ADP-ribose polymerase (PARP) and caspase-3. Nucleosides and nucleobases also trigger the release of cytochrome-c from the mitochondria by disruption of mitochondrial membrane potential and ROS formation. Furthermore, the use of zDEVD-fmk (caspase-3 inhibitor) and zLEHD-fmk (caspase-9 inhibitor) resulted in an inhibition of the activity of caspase-3 and 9, accompined with no change in the activity of caspase-8 after the use of zIETD-fmk (casapse-8 inhibitor). These findings implicate the involvement of the caspase-9-dependent mitochondrial pathway. Treatment with nucleosides also resulted in a concentration-dependent upregulation and translocation of the proapoptotic molecule Bax, increased expression of other proapoptotic proteins Bad, Bak, decreased expression of antiapoptotic proteins (i.e. Bcl-2 and Bcl-xL), and enhancement of p53 expression. Moreover, treatment with these agents resulted in accumulation of cells in the G0-G1 phase of the cell cycle, indicating the degradation of the cellular DNA. Interestingly, these nucleosides were found to posses anti-histone deacetyl transferase(s) (HDACs) potential, which is an exciting turn in cancer therapy. This conclusion was based on the observed decease in the expressed level of HDAC-1, -2 and -3. Our results suggest that these novel synthetic nucleosides can induce apoptosis via the mitochondrial pathway, and therefore they could be considered as candidate anti-tumor agents.

COinS